Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro

References

• Bussink J, Kaanders JH, van der Kogel AJ. Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003;67:3–15.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review. Cancer Res 1989;49:6449–65.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Alsner J, Keller J, Nielsen OS, Jensen OM, Horsman MR, . Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations. Br J Cancer 2001;84:1070–5.
   PubMed Web of Science ®Google Scholar
• Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31–9.
   PubMed Web of Science ®Google Scholar
• Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509–15.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285–9.
   PubMed Web of Science ®Google Scholar
• Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, . Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941–3.
   PubMed Web of Science ®Google Scholar
• Vordermark D, Brown JM. Evaluation of hypoxia-inducible factor-1alpha (HIF-1alpha) as an intrinsic marker of tumor hypoxia in U87 MG human glioblastoma: In vitro and xenograft studies. Int J Radiat Oncol Biol Phys 2003;56: 1184–93.
   PubMedGoogle Scholar
• Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, . Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res 2001;7:928–34.
   PubMed Web of Science ®Google Scholar
• Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, . GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding. Int J Cancer 2003;104:85–91.
   PubMed Web of Science ®Google Scholar
• Hoskin PJ, Sibtain A, Daley FM, Wilson GD. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: Relationship with vascularity and proliferation as predictors of outcome of ARCON. Br J Cancer 2003;89:1290–7.
   PubMed Web of Science ®Google Scholar
• Lukacova S, Khalil AA, Overgaard J, Alsner J, Horsman MR. Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum. Int J Radiat Biol 2005;81:937–44.
   PubMed Web of Science ®Google Scholar
• Sørensen BS, Hao J, Overgaard J, Vorum H, Honore B, Alsner J, . Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol 2005;76:187–93.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, . Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 2003;89:877–85.
   PubMed Web of Science ®Google Scholar
• Lukacova S, Sørensen BS, Alsner J, Overgaard J, Horsman MR. The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models. Acta Oncol 2007;47:941–7.
   Google Scholar
• Moon EJ, Brizel DM, Chi JT, Dewhirst MW. The potential role of intrinsic hypoxia markers as prognostic variables in cancer. Antioxid Redox Signal 2007;9:1237–94.
   PubMed Web of Science ®Google Scholar
• Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, . The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiother Oncol 2006;79:288–97.
   PubMed Web of Science ®Google Scholar
• Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, . Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 2001;93:1337–43.
   PubMed Web of Science ®Google Scholar
• Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, . Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 2001;61:8924–9.
   PubMed Web of Science ®Google Scholar
• Takagi H, King GL, Aiello LP. Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes 1998;47:1480–8.
   PubMed Web of Science ®Google Scholar
• Eriksen JG, Horsman MR. Tumour hypoxia – A characteristic feature with a complex molecular background. Radiother Oncol 2006;81:119–21.
   PubMedGoogle Scholar
• Chi JT, Wang Z, Nuyten DS, Rodriguez EH, Schaner ME, Salim A, . Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 2006;3:e47.
   PubMed Web of Science ®Google Scholar
• Seigneuric R, Starmans MH, Fung G, Krishnapuram B, Nuyten DS, van EA, . Impact of supervised gene signatures of early hypoxia on patient survival. Radiother Oncol 2007;83:374–82.
   PubMed Web of Science ®Google Scholar
• Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R, . Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003;22:5907–14.
   PubMed Web of Science ®Google Scholar
• Winter SC, Buffa FM, Silva P, Miller C, Valentine HR, Turley H, . Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. Cancer Res 2007;67:3441–9.
   PubMed Web of Science ®Google Scholar
• Stubbs M, McSheehy PM, Griffiths JR, Bashford CL. Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 2000;6:15–9.
   PubMedGoogle Scholar
• Brown JM, Wilson WR. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437–47.
   PubMed Web of Science ®Google Scholar
• Sutherland RM. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 1988; 240(4849):177–84.
   PubMed Web of Science ®Google Scholar
• Sutherland RM, Ausserer WA, Murphy BJ, Laderoute KR. Tumor hypoxia and heterogeneity: Challenges and opportunities for the future. Semin Radiat Oncol 1996;6:59–70.
   PubMedGoogle Scholar
• Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49: 4373–84.
   PubMed Web of Science ®Google Scholar
• Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med 1997;3: 177–82.
   PubMed Web of Science ®Google Scholar
• Sørensen BS, Alsner J, Overgaard J, Horsman MR. Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. Radiother Oncol 2007;83:362–6.
   PubMed Web of Science ®Google Scholar
• Chen JL, Lucas JE, Schroeder T, Mori S, Wu J, Nevins J, . The genomic analysis of lactic acidosis and acidosis response in human cancers. PLoS Genet 2008;4: e1000293.
   PubMed Web of Science ®Google Scholar
• Eicheler W, Zips D, Dorfler A, Grenman R, Baumann M. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. J Histochem Cytochem 2002;50:197–204.
   PubMed Web of Science ®Google Scholar
• Gautier L, Cope L, Bolstad BM, Irizarry RA. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004;20:307–15.
   PubMed Web of Science ®Google Scholar
• Ehrnrooth E, von der MH, Sørensen BS, Poulsen JH, Horsman MR. The ability of hypoxia to modify the gene expression of thymidylate synthase in tumour cells in vivo. Int J Radiat Biol 1999;75:885–91.
   PubMed Web of Science ®Google Scholar
• Lukacova S, Overgaard J, Alsner J, Horsman MR. Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models. Radiother Oncol 2006;80:165–71.
   PubMedGoogle Scholar
• Fitzpatrick TE, Graham CH. Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res 1998;245:155–62.
   PubMedGoogle Scholar
• Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P, . Coordinated induction of plasminogen activator inhibitor-1 (PAI-1) and inhibition of plasminogen activator gene expression by hypoxia promotes pulmonary vascular fibrin deposition. J Clin Invest 1998;102:919–28.
   PubMedGoogle Scholar
• Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, . Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883–7.
   PubMed Web of Science ®Google Scholar
• Bayer C, Schilling D, Hoetzel J, Egermann HP, Zips D, Yaromina A, . PAI-1 levels predict response to fractionated irradiation in 10 human squamous cell carcinoma lines of the head and neck. Radiother Oncol 2008;86: 361–8.
   PubMedGoogle Scholar
• Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A. Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res 2000;6:480–7.
   PubMed Web of Science ®Google Scholar
• Miki N, Ikuta M, Matsui T. Hypoxia-induced activation of the retinoic acid receptor-related orphan receptor alpha4 gene by an interaction between hypoxia-inducible factor-1 and Sp1. J Biol Chem 2004;279:15025–31.
   PubMedGoogle Scholar
• Chauvet C, Bois-Joyeux B, Danan JL. Retinoic acid receptor-related orphan receptor (ROR) alpha4 is the predominant isoform of the nuclear receptor RORalpha in the liver and is up-regulated by hypoxia in HepG2 human hepatoma cells. Biochem J 2002;364:449–56.
   PubMedGoogle Scholar
• Said HM, Stein S, Hagemann C, Polat B, Staab A, Anacker J, . Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Oncol Rep 2009; 21:237–46.
   PubMed Web of Science ®Google Scholar
• Chauvet C, Bois-Joyeux B, Berra E, Pouyssegur J, Danan JL. The gene encoding human retinoic acid-receptor-related orphan receptor alpha is a target for hypoxia-inducible factor 1. Biochem J 2004;384:79–85.
   PubMedGoogle Scholar
• Busk M, Horsman MR, Kristjansen PE, van der Kogel AJ, Bussink J, Overgaard J. Aerobic glycolysis in cancers: Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int J Cancer 2008;122:2726–34.
   PubMed Web of Science ®Google Scholar
• Pescador N, Cuevas Y, Naranjo S, Alcaide M, Villar D, Landazuri MO, . Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 2005; 390: 189–97.
   PubMedGoogle Scholar